1Tan Y,Sinniah R,Bay BH,et al.Metallothionein expression and nuclear size in benign,borderline,and malignant serous ovarian tumours[J].J Pathol 1999,189(1):60-65.
2Mocchegiani E,Giacconi R,Muti E,et al.Zinc,immune plasticity,aging,and successful aging:role of metallothionein[J].Ann N Y Acad Sci,2004,1019:127-134.
3Romero-Isart N,Jensen LT,Zerbe O,et al.Engineering of metallothionein-3 neuroinhibitory activity into the inactive isoform Metallothionein-1[J].J Biol Chem,2002,277(40):37023-37028.
4Raleigh JA,Chou SC,Calkins-Adams DP,et al.A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas[J].Clin Cancer Res,2000,6(3):855-862.
5Kondo Y,Woo ES,Michalska AE,et al.Metallothionein null cells have increased sensitivity to anticancer drugs[J].Cancer Res,1995,55(10):2021-2023.
6Hishikawa Y,Koji T,Dhar DK,et al.Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus[J].Br J Cancer,1999,81(4):712-720.
10Lee B J, Wang S G, Lee J C, et al. Level Ⅱb lymph node metastasis in neck dissection for papillary thyroid carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2007, 133(10) : 1028 -1030.
